{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:48:20Z","timestamp":1774442900576,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T00:00:00Z","timestamp":1451952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571442"],"award-info":[{"award-number":["81571442"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571613"],"award-info":[{"award-number":["81571613"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s13277-015-4672-8","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T01:53:14Z","timestamp":1451958794000},"page":"8359-8365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Human epididymis protein 4 expression positively correlated with miR-21 and served as a prognostic indicator in ovarian cancer"],"prefix":"10.1007","volume":"37","author":[{"given":"Yong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qicai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,5]]},"reference":[{"key":"4672_CR1","first-page":"3695","volume":"63","author":"I Hellstrom","year":"2003","unstructured":"Hellstrom I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res. 2003;63:3695\u2013700.","journal-title":"Cancer Res"},{"key":"4672_CR2","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1158\/1078-0432.CCR-05-2007","volume":"12","author":"N Scholler","year":"2006","unstructured":"Scholler N, Crawford M, Sato A, Drescher CW, O\u2019Briant KC, Kiviat N, et al. Bead-based ELISA for validation of ovarian cancer early detection markers. Clin Cancer Res. 2006;12:2117\u201324.","journal-title":"Clin Cancer Res"},{"key":"4672_CR3","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1158\/1078-0432.CCR-07-1442","volume":"14","author":"N Scholler","year":"2008","unstructured":"Scholler N, Lowe KA, Bergan LA, Kampani AV, Ng V, Forrest RM, et al. Use of yeast-secreted in vivo biotinylated recombinant antibodies (biobodies) in bead-based ELISA. Clin Cancer Res. 2008;14:2647\u201355.","journal-title":"Clin Cancer Res"},{"key":"4672_CR4","doi-asserted-by":"crossref","first-page":"12389","DOI":"10.1007\/s13277-014-2553-1","volume":"35","author":"T Vallius","year":"2014","unstructured":"Vallius T, Hynninen J, Auranen A, Carpen O, Matomaki J, Oksa S, et al. Serum HE4 and ca125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer. Tumour Biol. 2014;35:12389\u201395.","journal-title":"Tumour Biol"},{"key":"4672_CR5","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.3390\/ijms16022956","volume":"16","author":"T Huang","year":"2015","unstructured":"Huang T, Jiang SW, Qin L, Senkowski C, Lyle C, Terry K, et al. Expression and diagnostic value of HE4 in pancreatic adenocarcinoma. Int J Mol Sci. 2015;16:2956\u201370.","journal-title":"Int J Mol Sci"},{"key":"4672_CR6","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","volume":"19","author":"MT Galgano","year":"2006","unstructured":"Galgano MT, Hampton GM, Frierson Jr HF. Comprehensive analysis of HE4 expression in normal and malignant human tissues. Mod Pathol. 2006;19:847\u201353.","journal-title":"Mod Pathol"},{"key":"4672_CR7","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1074\/mcp.M600378-MCP200","volume":"6","author":"LV DeSouza","year":"2007","unstructured":"DeSouza LV, Grigull J, Ghanny S, Dube V, Romaschin AD, Colgan TJ, et al. Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics. 2007;6:1170\u201382.","journal-title":"Mol Cell Proteomics"},{"key":"4672_CR8","doi-asserted-by":"crossref","unstructured":"Jia LT, Zhang YC, Li J, Tian Y, Li JF. The role of human epididymis protein 4 in the diagnosis of epithelial ovarian cancer. Clin Transl Oncol. 2015.","DOI":"10.1007\/s12094-015-1365-0"},{"key":"4672_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/path.2964","volume":"226","author":"S Liu","year":"2012","unstructured":"Liu S, Kumar SM, Lu H, Liu A, Yang R, Pushparajan A, et al. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-kappaB1-Snail1 pathway in melanoma. J Pathol. 2012;226:61\u201372.","journal-title":"J Pathol"},{"key":"4672_CR10","first-page":"819","volume":"26","author":"Y Lou","year":"2010","unstructured":"Lou Y, Yang X, Wang F, Cui Z, Huang Y. MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. Int J Mol Med. 2010;26:819\u201327.","journal-title":"Int J Mol Med"},{"key":"4672_CR11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cca.2015.03.047","volume":"446","author":"T Granato","year":"2015","unstructured":"Granato T, Porpora MG, Longo F, Angeloni A, Manganaro L, Anastasi E. He4 in the differential diagnosis of ovarian masses. Clin Chim Acta. 2015;446:147\u201355.","journal-title":"Clin Chim Acta"},{"key":"4672_CR12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000430858","volume":"38","author":"Y Ikeda","year":"2015","unstructured":"Ikeda Y, Hasegawa K, Kurosaki A, Miyara A, Hanaoka T, Shintani D, et al. The risk of ovarian malignancy algorithm (ROMA) as a predictive marker of peritoneal dissemination in epithelial ovarian cancer patients. Oncol Res Treat. 2015;38:276\u201381.","journal-title":"Oncol Res Treat"},{"key":"4672_CR13","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1007\/s13277-014-1811-6","volume":"35","author":"J Wang","year":"2014","unstructured":"Wang J, Gao J, Yao H, Wu Z, Wang M, Qi J. Diagnostic accuracy of serum HE4, CA125 and ROMA in patients with ovarian cancer: a meta-analysis. Tumour Biol. 2014;35:6127\u201338.","journal-title":"Tumour Biol"},{"key":"4672_CR14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/1476-4598-13-243","volume":"13","author":"H Zhuang","year":"2014","unstructured":"Zhuang H, Tan M, Liu J, Hu Z, Liu D, Gao J, et al. Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells. Mol Cancer. 2014;13:243.","journal-title":"Mol Cancer"},{"key":"4672_CR15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1064921","volume":"294","author":"M Lagos-Quintana","year":"2001","unstructured":"Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294:853\u20138.","journal-title":"Science"},{"key":"4672_CR16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1582-4934.2008.00556.x","volume":"13","author":"AM Krichevsky","year":"2009","unstructured":"Krichevsky AM, Gabriely G. Mir-21: a small multi-faceted RNA. J Cell Mol Med. 2009;13:39\u201353.","journal-title":"J Cell Mol Med"},{"key":"4672_CR17","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4161\/rna.8.5.16154","volume":"8","author":"R Kumarswamy","year":"2011","unstructured":"Kumarswamy R, Volkmann I, Thum T. Regulation and function of miRNA-21 in health and disease. RNA Biol. 2011;8:706\u201313.","journal-title":"RNA Biol"},{"key":"4672_CR18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1158\/1541-7786.MCR-14-0424","volume":"13","author":"S Zhang","year":"2015","unstructured":"Zhang S, Lu Z, Unruh AK, Ivan C, Baggerly KA, Calin GA, et al. Clinically relevant microRNAs in ovarian cancer. Mol Cancer Res. 2015;13:393\u2013401.","journal-title":"Mol Cancer Res"},{"key":"4672_CR19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.7314\/APJCP.2013.14.2.1057","volume":"14","author":"YZ Xu","year":"2013","unstructured":"Xu YZ, Xi QH, Ge WL, Zhang XQ. Identification of serum microRNA-21 as a biomarker for early detection and prognosis in human epithelial ovarian cancer. Asian Pac J Cancer Prev. 2013;14:1057\u201360.","journal-title":"Asian Pac J Cancer Prev"},{"key":"4672_CR20","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ygyno.2014.01.034","volume":"132","author":"JK Chan","year":"2014","unstructured":"Chan JK, Blansit K, Kiet T, Sherman A, Wong G, Earle C, et al. The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer. Gynecol Oncol. 2014;132:739\u201344.","journal-title":"Gynecol Oncol"},{"key":"4672_CR21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/scrt247","volume":"4","author":"WM Chung","year":"2013","unstructured":"Chung WM, Chang WC, Chen L, Chang YY, Shyr CR, Hung YC, et al. MicroRNA-21 promotes the ovarian teratocarcinoma PA1 cell line by sustaining cancer stem\/progenitor populations in vitro. Stem Cell Res Ther. 2013;4:88.","journal-title":"Stem Cell Res Ther"},{"key":"4672_CR22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/molehr\/gap093","volume":"16","author":"Q Pan","year":"2010","unstructured":"Pan Q, Luo X, Chegini N. MicroRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells. Mol Hum Reprod. 2010;16:215\u201327.","journal-title":"Mol Hum Reprod"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4672-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4672-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4672-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4672-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T01:31:50Z","timestamp":1567474310000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4672-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,5]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["4672"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4672-8","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,5]]}}}